SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-295380
Filing Date
2022-11-30
Accepted
2022-11-30 16:07:01
Documents
13
Period of Report
2022-11-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d405464d8k.htm   iXBRL 8-K 29788
2 EX-3.1 d405464dex31.htm EX-3.1 9300
  Complete submission text file 0001193125-22-295380.txt   168563

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20221130.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20221130_lab.xml EX-101.LAB 18723
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20221130_pre.xml EX-101.PRE 11708
7 EXTRACTED XBRL INSTANCE DOCUMENT d405464d8k_htm.xml XML 3575
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 221435660
SIC: 8090 Services-Misc Health & Allied Services, NEC